Aminohippurate Sodium

   
Google
 
Web NewDrugInformation.com

Aminohippurate Sodium


Drug - Aminohippurate Sodium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aminohippurate Sodium
Multiple ingredients are in alphabetical order.

Strength - 20%
The potency of the active ingredient(s), Aminohippurate Sodium. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Aminohippurate Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 005619
The FDA assigned number to Aminohippurate Sodium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Aminohippurate Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Aminohippurate Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Aminohippurate Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Aminohippurate Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck And Co Inc
The full name of the firm holding legal responsibility for the new application of Aminohippurate Sodium.

Aminohippurate Sodium